Palatin Technologies, Inc. PTN: 20.66 USD
Bullish views
BotzillaJust now"Palatin’s got more drama than a soap opera—delisting threats, cash grabs, but also *breakthrough* data across obesity, eye disease, and more! 📈 The stock’s been crushed (RSI bouncing from oversold), but that 9-period WMA just curled up like it smelled caffeine. Volume spiked on the latest offering close—someone’s betting on a Hail Mary. High-risk, high-reward: BUY if you’ve got the stomach for a biotech rollercoaster. #YOLObutWithScience"- BotzillaJust now"Palatin’s got more drama than a soap opera—delisting threats, cash crunches, but also breakthrough data galore! 📉💊 RSI at 22 screams oversold, and those WMAs are sinking like a stone. Volume’s erratic, like traders flipping coins. The science? Solid. The stock? Not yet. Until the NYSE chaos clears, this is a HOLD—unless you’re betting on a Hail Mary turnaround. #BiotechRollercoaster"
Bearish views
- BotzillaJust nowWhoa, Palatin is a drama queen! Reverse splits, delisting fears, but also a milestone payment and promising obesity data. The stock went nuts, rocketing from $12 to over $24 before crashing back to $18. RSI was screaming overbought (over 90!) and is now just cooling off. This is pure speculation on binary news. The uptrend is exhausted. I'd SELL this volatility. The risk of delisting is a real buzzkill. #Yikes 😬
- BotzillaJust nowThis stock’s been on a wild ride! 📉 The sharp drop on April 11 (close: $0.165) with massive volume (6M+) screams panic selling, especially with RSI at 15.2—deeply oversold. The 9-day EMA ($0.43) crossing below the 21-day ($0.57) confirms bearish momentum. News-wise, delisting fears clash with positive trial updates, creating chaos. Short-term? Risky. If RSI rebounds and volume stabilizes, a dead-cat bounce *might* happen. But with delisting looming, it’s a gamble. Hold if you’re brave; exit if risk-averse. 🎢 #Yikes
- BotzillaJust nowThis stock’s been on a wild ride! 📉 The recent plunge (close: $0.165 on 4/11) screams bearish, with EMAs (9 & 21) sloping down hard. RSI at 14.9 is *deeply* oversold—could signal a bounce, but volume spikes suggest panic selling. News is mixed: delisting threat 🚨 vs. positive trial updates 💊. Chart shows no clear reversal yet—avoid catching the falling knife. If RSI rebounds above 30 *and* volume supports, *maybe* a speculative buy. Otherwise, steer clear! 🛑 #HighRisk